| + |
T_cell_activation | up-regulates quantity
|
IL17A |
0.7 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-263819 |
|
|
Homo sapiens |
Helper T-lymphocyte |
| pmid |
sentence |
| 32454942 |
interferon gamma- (IFNγ-) and interleukin-17- (IL-17-) secreting CD4+ T cells are believed to be the pathogenic initiators of MS [22], and in MS patients, the increased production of either IFNγ or IL-17 is associated with pathology |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| Pathways: | Multiple sclerosis |
| + |
IL17A | up-regulates
transcriptional regulation
|
KLF3 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-210114 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 23332504 |
Specifically, il-17 suppresses klf15, a pro-adipogenic tf, and enhances expression of klf2 and klf3, which are anti-adipogenic. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL17A | up-regulates
transcriptional regulation
|
KLF2 |
0.284 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-210111 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 23332504 |
Specifically, il-17 suppresses klf15, a pro-adipogenic tf, and enhances expression of klf2 and klf3, which are anti-adipogenic. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL17A | down-regulates quantity by repression
transcriptional regulation
|
KLF15 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-192474 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 23332504 |
Specifically, il-17 suppresses klf15, a pro-adipogenic tf, and enhances expression of klf2 and klf3, which are anti-adipogenic. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL17A | up-regulates quantity by expression
transcriptional regulation
|
KLF2 |
0.284 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-192477 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 23332504 |
Specifically, il-17 suppresses klf15, a pro-adipogenic tf, and enhances expression of klf2 and klf3, which are anti-adipogenic. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
NFKBIZ | up-regulates quantity by expression
transcriptional regulation
|
IL17A |
0.381 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-266210 |
|
|
Mus musculus |
T-lymphocyte |
| pmid |
sentence |
| 20383124 |
In cooperation with RORγt and RORα, IκBζ enhances Il17a expression by binding directly to the regulatory region of the Il17a gene. |
|
| Publications: |
1 |
Organism: |
Mus Musculus |
| + |
SMAD2/STAT3/EP300 | up-regulates
transcriptional regulation
|
IL17A |
0.478 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-255027 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 26194464 |
Thus, pSmad2L (Ser255) forms complex with p300 and STAT3 to bind to the proximal promoter of the Rorc and Il17a genes. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL17A | up-regulates
binding
|
IL17RA |
0.924 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-53249 |
|
|
Homo sapiens |
T-lymphocyte |
| pmid |
sentence |
| 9367539 |
Binding studies suggest that recombinant hil-17 binds to the hil-17r with low affinity. Monoclonal antibodies (mabs) generated against the hil-17r were able to block the il-17-induced production of cytokine from human foreskin fibroblast (hff) cells. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
Secukinumab (Cosentyx) | down-regulates activity
binding
|
IL17A |
0.4 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-272494 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 30793255 |
Secukinumab (Cosentyx®), a first-in-class fully human monoclonal antibody against interleukin-17A |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL17A | up-regulates quantity by expression
transcriptional regulation
|
KRT17 |
0.342 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-255232 |
|
|
Homo sapiens |
Keratinocyte |
| pmid |
sentence |
| 21796151 |
IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL17A | up-regulates quantity by expression
transcriptional regulation
|
KLF3 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-192610 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 23332504 |
Specifically, il-17 suppresses klf15, a pro-adipogenic tf, and enhances expression of klf2 and klf3, which are anti-adipogenic. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
RORC | up-regulates
transcriptional regulation
|
IL17A |
0.541 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-255029 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 16990136 |
We found that RORgt is required for the constitutive expression of IL-17 in intestinal lamina propria T cells and for the in vitro differentiation of Th17 cells from naive CD4+ T cells |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL17A | up-regulates activity
binding
|
IL17R complex |
0.806 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-261337 |
|
|
Homo sapiens |
Myofibroblast |
| pmid |
sentence |
| 32024054 |
Importantly, IL-17 was involved in increased collagen production in cardiac fibroblasts in response to HG, with both subunits of the IL-17RA and IL-17RC heterodimer complex being important to mediating this response. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| Pathways: | Multiple sclerosis |